These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6977593)

  • 41. Inhibition of graft rejection by LPS: further evidence for effects on T lymphocytes.
    Winchurch RA; Hilberg C; Birmingham W; Munster AM
    J Reticuloendothel Soc; 1982 Jan; 31(1):31-42. PubMed ID: 6977643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell-mediated hyperacute rejection. VI. Prolonged survival of heterotopic mouse heart transplants.
    Shelby J; Wakely E; Jorgensen C; Eichwald EJ
    J Surg Res; 1986 Feb; 40(2):133-7. PubMed ID: 3511323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.
    Schultz KR; Paquet J; Bader S; HayGlass KT
    Bone Marrow Transplant; 1995 Aug; 16(2):289-95. PubMed ID: 7581150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity.
    Levitsky HI; Montgomery J; Ahmadzadeh M; Staveley-O'Carroll K; Guarnieri F; Longo DL; Kwak LW
    J Immunol; 1996 May; 156(10):3858-65. PubMed ID: 8621924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salmonella abortusovis infection in susceptible BALB/cby mice: importance of Lyt-2+ and L3T4+ T cells in acquired immunity and granuloma formation.
    Guilloteau L; Buzoni-Gatel D; Bernard F; Lantier I; Lantier F
    Microb Pathog; 1993 Jan; 14(1):45-55. PubMed ID: 8321117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of subpopulations of glass-adherent mouse skin cells controlling resistance/susceptibility to infection with Leishmania tropica, and correlation with the development of independent proliferative signals to Lyt-1+/Lyt-2+ T lymphocytes.
    Gorczynski RM; MacRae S
    Cell Immunol; 1982 Feb; 67(1):74-89. PubMed ID: 6978770
    [No Abstract]   [Full Text] [Related]  

  • 49. [Transfer agent of immunity (author's transl)].
    Mitsuhashi S; Kurashige S
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):900-6. PubMed ID: 4612619
    [No Abstract]   [Full Text] [Related]  

  • 50. The Lyt-2, Lyt-3 macromolecules: structural and functional studies.
    Ledbetter JA; Seaman WE
    Immunol Rev; 1982; 68():197-218. PubMed ID: 6757107
    [No Abstract]   [Full Text] [Related]  

  • 51. Cell-mediated hyperacute rejection. I. Acute, accelerated, and hyperacute reactions.
    Emam M; Eichwald EJ
    Transplantation; 1981 Mar; 31(3):156-9. PubMed ID: 7015608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell-mediated hyperacute rejection. II. The early events.
    Moatamed F; Taylor JV; Emam M; Eichwald EJ
    Cell Immunol; 1981 Mar; 59(1):219-24. PubMed ID: 7214545
    [No Abstract]   [Full Text] [Related]  

  • 53. Specific adoptive immunotherapy: experimental basis and future potential.
    Greenberg PD; Cheever MA; Fefer A
    Surv Immunol Res; 1982; 1(1):85-90. PubMed ID: 6764836
    [No Abstract]   [Full Text] [Related]  

  • 54. Cell-mediated hyperacute rejection. III. Genetic determinants.
    Eichwald EJ; Barstad R; Graves G
    Immunogenetics; 1981; 14(3-4):351-5. PubMed ID: 7037628
    [No Abstract]   [Full Text] [Related]  

  • 55. Cell-mediated hyperacute rejection. IV. Lyt markers and adoptive transfer.
    Eichwald EJ; Jorgensen C; Graves G
    J Immunol; 1982 May; 128(5):2373-4. PubMed ID: 6977593
    [No Abstract]   [Full Text] [Related]  

  • 56. Cell-mediated hyperacute rejection. VIII. The recipient's role in adoptive transfer.
    Eichwald EJ; Bernhard EJ; Jorgensen C
    Transplantation; 1985 Feb; 39(2):219-20. PubMed ID: 3871543
    [No Abstract]   [Full Text] [Related]  

  • 57. Lyt-1 cells mediate acute murine experimental allergic encephalomyelitis.
    Hauser SL; Weiner HL; Bhan AK; Shapiro ME; Che M; Aldrich WR; Letvin NL
    J Immunol; 1984 Nov; 133(5):2288-90. PubMed ID: 6332841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transfer of sensitised Lyt 2+ cells triggers acute rejection of pancreatic islet allografts.
    Prowse SJ; Warren HS; Agostino M; Lafferty KJ
    Aust J Exp Biol Med Sci; 1983 Apr; 61 (Pt 2)():181-5. PubMed ID: 6411053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Graft rejection and T cells].
    Nakayama E
    Nihon Rinsho; 1985 Jan; 43(1):104-8. PubMed ID: 3886950
    [No Abstract]   [Full Text] [Related]  

  • 60. Which T cells cause graft rejection?
    Loveland BE; McKenzie IF
    Transplantation; 1982 Mar; 33(3):217-21. PubMed ID: 6801833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.